 | • レポートコード：GIR201105745 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、髄膜炎菌感染症薬の世界市場を調査対象にし、髄膜炎菌感染症薬の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（MGBBP-3、NCL-195、TP-10、その他）、用途別分析（病院、クリニック、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Beijing Minhai Biotechnology Co Ltd、MGB Biopharma Ltd、GlaxoSmithKline Plc、Biological E Ltd、JN-International Medical Corp、China National Pharmaceutical Group Corp、Pfizer Inc、ImmunoBiology Ltd、Griffith University、Panacea Biotec Ltd、Sanofi Pasteur SA、Serum Institute of India Ltd、Wellstat Vaccines LLC ・メーカー別販売量、売上、市場シェア ・髄膜炎菌感染症薬の地域別市場分析 ・髄膜炎菌感染症薬の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・髄膜炎菌感染症薬のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・髄膜炎菌感染症薬のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・髄膜炎菌感染症薬の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・髄膜炎菌感染症薬の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・髄膜炎菌感染症薬の種類別市場規模2015-2020：MGBBP-3、NCL-195、TP-10、その他 ・髄膜炎菌感染症薬の用途別市場規模2015-2020：病院、クリニック、その他 ・髄膜炎菌感染症薬の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Neisseria meningitidis Infections Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Neisseria meningitidis Infections Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Neisseria meningitidis Infections Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Neisseria meningitidis Infections Drug market has been segmented into
MGBBP-3
NCL-195
TP-10
Others
By Application, Neisseria meningitidis Infections Drug has been segmented into:
Hospital
Clinic
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Neisseria meningitidis Infections Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Neisseria meningitidis Infections Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Neisseria meningitidis Infections Drug market.
The report offers in-depth assessment of the growth and other aspects of the Neisseria meningitidis Infections Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Neisseria meningitidis Infections Drug Market Share Analysis
Neisseria meningitidis Infections Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Neisseria meningitidis Infections Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Neisseria meningitidis Infections Drug sales, revenue and market share for each player covered in this report.
The major players covered in Neisseria meningitidis Infections Drug are:
Beijing Minhai Biotechnology Co Ltd
MGB Biopharma Ltd
GlaxoSmithKline Plc
Biological E Ltd
JN-International Medical Corp
China National Pharmaceutical Group Corp
Pfizer Inc
ImmunoBiology Ltd
Griffith University
Panacea Biotec Ltd
Sanofi Pasteur SA
Serum Institute of India Ltd
Wellstat Vaccines LLC
Among other players domestic and global, Neisseria meningitidis Infections Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Neisseria meningitidis Infections Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Neisseria meningitidis Infections Drug, with price, sales, revenue and global market share of Neisseria meningitidis Infections Drug in 2018 and 2019.
Chapter 3, the Neisseria meningitidis Infections Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Neisseria meningitidis Infections Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Neisseria meningitidis Infections Drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Neisseria meningitidis Infections Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Neisseria meningitidis Infections Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Neisseria meningitidis Infections Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 MGBBP-3
1.2.3 NCL-195
1.2.4 TP-10
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Neisseria meningitidis Infections Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Overview of Global Neisseria meningitidis Infections Drug Market
1.4.1 Global Neisseria meningitidis Infections Drug Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Beijing Minhai Biotechnology Co Ltd
2.1.1 Beijing Minhai Biotechnology Co Ltd Details
2.1.2 Beijing Minhai Biotechnology Co Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Beijing Minhai Biotechnology Co Ltd SWOT Analysis
2.1.4 Beijing Minhai Biotechnology Co Ltd Product and Services
2.1.5 Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 MGB Biopharma Ltd
2.2.1 MGB Biopharma Ltd Details
2.2.2 MGB Biopharma Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 MGB Biopharma Ltd SWOT Analysis
2.2.4 MGB Biopharma Ltd Product and Services
2.2.5 MGB Biopharma Ltd Neisseria meningitidis Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 GlaxoSmithKline Plc
2.3.1 GlaxoSmithKline Plc Details
2.3.2 GlaxoSmithKline Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 GlaxoSmithKline Plc SWOT Analysis
2.3.4 GlaxoSmithKline Plc Product and Services
2.3.5 GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Biological E Ltd
2.4.1 Biological E Ltd Details
2.4.2 Biological E Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Biological E Ltd SWOT Analysis
2.4.4 Biological E Ltd Product and Services
2.4.5 Biological E Ltd Neisseria meningitidis Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 JN-International Medical Corp
2.5.1 JN-International Medical Corp Details
2.5.2 JN-International Medical Corp Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 JN-International Medical Corp SWOT Analysis
2.5.4 JN-International Medical Corp Product and Services
2.5.5 JN-International Medical Corp Neisseria meningitidis Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 China National Pharmaceutical Group Corp
2.6.1 China National Pharmaceutical Group Corp Details
2.6.2 China National Pharmaceutical Group Corp Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 China National Pharmaceutical Group Corp SWOT Analysis
2.6.4 China National Pharmaceutical Group Corp Product and Services
2.6.5 China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Pfizer Inc
2.7.1 Pfizer Inc Details
2.7.2 Pfizer Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Pfizer Inc SWOT Analysis
2.7.4 Pfizer Inc Product and Services
2.7.5 Pfizer Inc Neisseria meningitidis Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 ImmunoBiology Ltd
2.8.1 ImmunoBiology Ltd Details
2.8.2 ImmunoBiology Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 ImmunoBiology Ltd SWOT Analysis
2.8.4 ImmunoBiology Ltd Product and Services
2.8.5 ImmunoBiology Ltd Neisseria meningitidis Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Griffith University
2.9.1 Griffith University Details
2.9.2 Griffith University Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Griffith University SWOT Analysis
2.9.4 Griffith University Product and Services
2.9.5 Griffith University Neisseria meningitidis Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Panacea Biotec Ltd
2.10.1 Panacea Biotec Ltd Details
2.10.2 Panacea Biotec Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Panacea Biotec Ltd SWOT Analysis
2.10.4 Panacea Biotec Ltd Product and Services
2.10.5 Panacea Biotec Ltd Neisseria meningitidis Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Sanofi Pasteur SA
2.11.1 Sanofi Pasteur SA Details
2.11.2 Sanofi Pasteur SA Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Sanofi Pasteur SA SWOT Analysis
2.11.4 Sanofi Pasteur SA Product and Services
2.11.5 Sanofi Pasteur SA Neisseria meningitidis Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Serum Institute of India Ltd
2.12.1 Serum Institute of India Ltd Details
2.12.2 Serum Institute of India Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Serum Institute of India Ltd SWOT Analysis
2.12.4 Serum Institute of India Ltd Product and Services
2.12.5 Serum Institute of India Ltd Neisseria meningitidis Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Wellstat Vaccines LLC
2.13.1 Wellstat Vaccines LLC Details
2.13.2 Wellstat Vaccines LLC Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Wellstat Vaccines LLC SWOT Analysis
2.13.4 Wellstat Vaccines LLC Product and Services
2.13.5 Wellstat Vaccines LLC Neisseria meningitidis Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Neisseria meningitidis Infections Drug Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Neisseria meningitidis Infections Drug Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Neisseria meningitidis Infections Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Neisseria meningitidis Infections Drug Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Neisseria meningitidis Infections Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Neisseria meningitidis Infections Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global Neisseria meningitidis Infections Drug Revenue and Market Share by Regions (2015-2020)
4.2 North America Neisseria meningitidis Infections Drug Sales and Growth Rate (2015-2020)
4.3 Europe Neisseria meningitidis Infections Drug Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Neisseria meningitidis Infections Drug Sales and Growth Rate (2015-2020)
4.5 South America Neisseria meningitidis Infections Drug Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Neisseria meningitidis Infections Drug Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Neisseria meningitidis Infections Drug Sales, Revenue and Market Share by Country
5.1.1 North America Neisseria meningitidis Infections Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Neisseria meningitidis Infections Drug Revenue and Market Share by Country (2015-2020)
5.2 United States Neisseria meningitidis Infections Drug Sales and Growth Rate (2015-2020)
5.3 Canada Neisseria meningitidis Infections Drug Sales and Growth Rate (2015-2020)
5.4 Mexico Neisseria meningitidis Infections Drug Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Neisseria meningitidis Infections Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Neisseria meningitidis Infections Drug Sales and Market Share by Country (2015-2020)
6.1.2 Europe Neisseria meningitidis Infections Drug Revenue and Market Share by Country (2015-2020)
6.2 Germany Neisseria meningitidis Infections Drug Sales and Growth Rate (2015-2020)
6.3 UK Neisseria meningitidis Infections Drug Sales and Growth Rate (2015-2020)
6.4 France Neisseria meningitidis Infections Drug Sales and Growth Rate (2015-2020)
6.5 Russia Neisseria meningitidis Infections Drug Sales and Growth Rate (2015-2020)
6.6 Italy Neisseria meningitidis Infections Drug Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Neisseria meningitidis Infections Drug Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Neisseria meningitidis Infections Drug Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Neisseria meningitidis Infections Drug Revenue and Market Share by Regions (2015-2020)
7.2 China Neisseria meningitidis Infections Drug Sales and Growth Rate (2015-2020)
7.3 Japan Neisseria meningitidis Infections Drug Sales and Growth Rate (2015-2020)
7.4 Korea Neisseria meningitidis Infections Drug Sales and Growth Rate (2015-2020)
7.5 India Neisseria meningitidis Infections Drug Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Neisseria meningitidis Infections Drug Sales and Growth Rate (2015-2020)
7.7 Australia Neisseria meningitidis Infections Drug Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Neisseria meningitidis Infections Drug Sales, Revenue and Market Share by Country
8.1.1 South America Neisseria meningitidis Infections Drug Sales and Market Share by Country (2015-2020)
8.1.2 South America Neisseria meningitidis Infections Drug Revenue and Market Share by Country (2015-2020)
8.2 Brazil Neisseria meningitidis Infections Drug Sales and Growth Rate (2015-2020)
8.3 Argentina Neisseria meningitidis Infections Drug Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Neisseria meningitidis Infections Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Neisseria meningitidis Infections Drug Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Neisseria meningitidis Infections Drug Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Neisseria meningitidis Infections Drug Sales and Growth Rate (2015-2020)
9.3 Turkey Neisseria meningitidis Infections Drug Sales and Growth Rate (2015-2020)
9.4 Egypt Neisseria meningitidis Infections Drug Sales and Growth Rate (2015-2020)
9.5 South Africa Neisseria meningitidis Infections Drug Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Neisseria meningitidis Infections Drug Sales and Market Share by Type (2015-2020)
10.2 Global Neisseria meningitidis Infections Drug Revenue and Market Share by Type (2015-2020)
10.3 Global Neisseria meningitidis Infections Drug Price by Type (2015-2020)
11 Global Neisseria meningitidis Infections Drug Market Segment by Application
11.1 Global Neisseria meningitidis Infections Drug Sales Market Share by Application (2015-2020)
11.2 Global Neisseria meningitidis Infections Drug Revenue Market Share by Application (2015-2020)
11.3 Global Neisseria meningitidis Infections Drug Price by Application (2015-2020)
12 Market Forecast
12.1 Global Neisseria meningitidis Infections Drug Sales, Revenue and Growth Rate (2021-2025)
12.2 Neisseria meningitidis Infections Drug Market Forecast by Regions (2021-2025)
12.2.1 North America Neisseria meningitidis Infections Drug Market Forecast (2021-2025)
12.2.2 Europe Neisseria meningitidis Infections Drug Market Forecast (2021-2025)
12.2.3 Asia-Pacific Neisseria meningitidis Infections Drug Market Forecast (2021-2025)
12.2.4 South America Neisseria meningitidis Infections Drug Market Forecast (2021-2025)
12.2.5 Middle East & Africa Neisseria meningitidis Infections Drug Market Forecast (2021-2025)
12.3 Neisseria meningitidis Infections Drug Market Forecast by Type (2021-2025)
12.3.1 Global Neisseria meningitidis Infections Drug Sales Forecast by Type (2021-2025)
12.3.2 Global Neisseria meningitidis Infections Drug Market Share Forecast by Type (2021-2025)
12.4 Neisseria meningitidis Infections Drug Market Forecast by Application (2021-2025)
12.4.1 Global Neisseria meningitidis Infections Drug Sales Forecast by Application (2021-2025)
12.4.2 Global Neisseria meningitidis Infections Drug Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Neisseria meningitidis Infections Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Neisseria meningitidis Infections Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Neisseria meningitidis Infections Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Beijing Minhai Biotechnology Co Ltd Basic Information, Manufacturing Base and Competitors
Table 8. Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Major Business
Table 9. Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Total Revenue (USD Million) (2018-2019)
Table 10. Beijing Minhai Biotechnology Co Ltd SWOT Analysis
Table 11. Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Product and Services
Table 12. Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. MGB Biopharma Ltd Basic Information, Manufacturing Base and Competitors
Table 14. MGB Biopharma Ltd Neisseria meningitidis Infections Drug Major Business
Table 15. MGB Biopharma Ltd Neisseria meningitidis Infections Drug Total Revenue (USD Million) (2018-2019)
Table 16. MGB Biopharma Ltd SWOT Analysis
Table 17. MGB Biopharma Ltd Neisseria meningitidis Infections Drug Product and Services
Table 18. MGB Biopharma Ltd Neisseria meningitidis Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. GlaxoSmithKline Plc Basic Information, Manufacturing Base and Competitors
Table 20. GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Major Business
Table 21. GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Total Revenue (USD Million) (2018-2019)
Table 22. GlaxoSmithKline Plc SWOT Analysis
Table 23. GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Product and Services
Table 24. GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Biological E Ltd Basic Information, Manufacturing Base and Competitors
Table 26. Biological E Ltd Neisseria meningitidis Infections Drug Major Business
Table 27. Biological E Ltd Neisseria meningitidis Infections Drug Total Revenue (USD Million) (2018-2019)
Table 28. Biological E Ltd SWOT Analysis
Table 29. Biological E Ltd Neisseria meningitidis Infections Drug Product and Services
Table 30. Biological E Ltd Neisseria meningitidis Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. JN-International Medical Corp Basic Information, Manufacturing Base and Competitors
Table 32. JN-International Medical Corp Neisseria meningitidis Infections Drug Major Business
Table 33. JN-International Medical Corp Neisseria meningitidis Infections Drug Total Revenue (USD Million) (2018-2019)
Table 34. JN-International Medical Corp SWOT Analysis
Table 35. JN-International Medical Corp Neisseria meningitidis Infections Drug Product and Services
Table 36. JN-International Medical Corp Neisseria meningitidis Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. China National Pharmaceutical Group Corp Basic Information, Manufacturing Base and Competitors
Table 38. China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Major Business
Table 39. China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Total Revenue (USD Million) (2018-2019)
Table 40. China National Pharmaceutical Group Corp SWOT Analysis
Table 41. China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Product and Services
Table 42. China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 44. Pfizer Inc Neisseria meningitidis Infections Drug Major Business
Table 45. Pfizer Inc Neisseria meningitidis Infections Drug Total Revenue (USD Million) (2018-2019)
Table 46. Pfizer Inc SWOT Analysis
Table 47. Pfizer Inc Neisseria meningitidis Infections Drug Product and Services
Table 48. Pfizer Inc Neisseria meningitidis Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. ImmunoBiology Ltd Basic Information, Manufacturing Base and Competitors
Table 50. ImmunoBiology Ltd Neisseria meningitidis Infections Drug Major Business
Table 51. ImmunoBiology Ltd Neisseria meningitidis Infections Drug Total Revenue (USD Million) (2018-2019)
Table 52. ImmunoBiology Ltd SWOT Analysis
Table 53. ImmunoBiology Ltd Neisseria meningitidis Infections Drug Product and Services
Table 54. ImmunoBiology Ltd Neisseria meningitidis Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Griffith University Basic Information, Manufacturing Base and Competitors
Table 56. Griffith University Neisseria meningitidis Infections Drug Major Business
Table 57. Griffith University Neisseria meningitidis Infections Drug Total Revenue (USD Million) (2018-2019)
Table 58. Griffith University SWOT Analysis
Table 59. Griffith University Neisseria meningitidis Infections Drug Product and Services
Table 60. Griffith University Neisseria meningitidis Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Panacea Biotec Ltd Basic Information, Manufacturing Base and Competitors
Table 62. Panacea Biotec Ltd Neisseria meningitidis Infections Drug Major Business
Table 63. Panacea Biotec Ltd Neisseria meningitidis Infections Drug Total Revenue (USD Million) (2018-2019)
Table 64. Panacea Biotec Ltd SWOT Analysis
Table 65. Panacea Biotec Ltd Neisseria meningitidis Infections Drug Product and Services
Table 66. Panacea Biotec Ltd Neisseria meningitidis Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Sanofi Pasteur SA Basic Information, Manufacturing Base and Competitors
Table 68. Sanofi Pasteur SA Neisseria meningitidis Infections Drug Major Business
Table 69. Sanofi Pasteur SA Neisseria meningitidis Infections Drug Total Revenue (USD Million) (2018-2019)
Table 70. Sanofi Pasteur SA SWOT Analysis
Table 71. Sanofi Pasteur SA Neisseria meningitidis Infections Drug Product and Services
Table 72. Sanofi Pasteur SA Neisseria meningitidis Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Serum Institute of India Ltd Basic Information, Manufacturing Base and Competitors
Table 74. Serum Institute of India Ltd Neisseria meningitidis Infections Drug Major Business
Table 75. Serum Institute of India Ltd Neisseria meningitidis Infections Drug Total Revenue (USD Million) (2018-2019)
Table 76. Serum Institute of India Ltd SWOT Analysis
Table 77. Serum Institute of India Ltd Neisseria meningitidis Infections Drug Product and Services
Table 78. Serum Institute of India Ltd Neisseria meningitidis Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Wellstat Vaccines LLC Basic Information, Manufacturing Base and Competitors
Table 80. Wellstat Vaccines LLC Neisseria meningitidis Infections Drug Major Business
Table 81. Wellstat Vaccines LLC Neisseria meningitidis Infections Drug Total Revenue (USD Million) (2018-2019)
Table 82. Wellstat Vaccines LLC SWOT Analysis
Table 83. Wellstat Vaccines LLC Neisseria meningitidis Infections Drug Product and Services
Table 84. Wellstat Vaccines LLC Neisseria meningitidis Infections Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Global Neisseria meningitidis Infections Drug Sales by Manufacturer (2018-2019) (K Pcs)
Table 86. Global Neisseria meningitidis Infections Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 87. Global Neisseria meningitidis Infections Drug Sales by Regions (2015-2020) (K Pcs)
Table 88. Global Neisseria meningitidis Infections Drug Sales Market Share by Regions (2015-2020)
Table 89. Global Neisseria meningitidis Infections Drug Revenue by Regions (2015-2020) (USD Million)
Table 90. North America Neisseria meningitidis Infections Drug Sales by Countries (2015-2020) (K Pcs)
Table 91. North America Neisseria meningitidis Infections Drug Sales Market Share by Countries (2015-2020)
Table 92. North America Neisseria meningitidis Infections Drug Revenue by Countries (2015-2020) (USD Million)
Table 93. North America Neisseria meningitidis Infections Drug Revenue Market Share by Countries (2015-2020)
Table 94. Europe Neisseria meningitidis Infections Drug Sales by Countries (2015-2020) (K Pcs)
Table 95. Europe Neisseria meningitidis Infections Drug Sales Market Share by Countries (2015-2020)
Table 96. Europe Neisseria meningitidis Infections Drug Revenue by Countries (2015-2020) (USD Million)
Table 97. Asia-Pacific Neisseria meningitidis Infections Drug Sales by Regions (2015-2020) (K Pcs)
Table 98. Asia-Pacific Neisseria meningitidis Infections Drug Sales Market Share by Regions (2015-2020)
Table 99. Asia-Pacific Neisseria meningitidis Infections Drug Revenue by Regions (2015-2020) (USD Million)
Table 100. South America Neisseria meningitidis Infections Drug Sales by Countries (2015-2020) (K Pcs)
Table 101. South America Neisseria meningitidis Infections Drug Sales Market Share by Countries (2015-2020)
Table 102. South America Neisseria meningitidis Infections Drug Revenue by Countries (2015-2020) (USD Million)
Table 103. South America Neisseria meningitidis Infections Drug Revenue Market Share by Countries (2015-2020)
Table 104. Middle East & Africa Neisseria meningitidis Infections Drug Sales by Countries (2015-2020) (K Pcs)
Table 105. Middle East & Africa Neisseria meningitidis Infections Drug Sales Market Share by Countries (2015-2020)
Table 106. Middle East & Africa Neisseria meningitidis Infections Drug Revenue by Countries (2015-2020) (USD Million)
Table 107. Middle East & Africa Neisseria meningitidis Infections Drug Revenue Market Share by Countries (2015-2020)
Table 108. Global Neisseria meningitidis Infections Drug Sales by Type (2015-2020) (K Pcs)
Table 109. Global Neisseria meningitidis Infections Drug Sales Share by Type (2015-2020)
Table 110. Global Neisseria meningitidis Infections Drug Revenue by Type (2015-2020) (USD Million)
Table 111. Global Neisseria meningitidis Infections Drug Revenue Share by Type (2015-2020)
Table 112. Global Neisseria meningitidis Infections Drug Sales by Application (2015-2020) (K Pcs)
Table 113. Global Neisseria meningitidis Infections Drug Sales Share by Application (2015-2020)
Table 114. Global Neisseria meningitidis Infections Drug Sales Forecast by Regions (2021-2025) (K Pcs)
Table 115. Global Neisseria meningitidis Infections Drug Market Share Forecast by Regions (2021-2025)
Table 116. Global Neisseria meningitidis Infections Drug Sales Forecast by Type (2021-2025) (K Pcs)
Table 117. Global Neisseria meningitidis Infections Drug Market Share Forecast by Type (2021-2025)
Table 118. Global Neisseria meningitidis Infections Drug Sales Forecast by Application (2021-2025)
Table 119. Global Neisseria meningitidis Infections Drug Market Share Forecast by Application (2021-2025)
Table 120. Direct Channel Pros & Cons
Table 121. Indirect Channel Pros & Cons
Table 122. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Neisseria meningitidis Infections Drug Picture
Figure 2. Global Sales Market Share of Neisseria meningitidis Infections Drug by Type in 2019
Figure 3. MGBBP-3 Picture
Figure 4. NCL-195 Picture
Figure 5. TP-10 Picture
Figure 6. Others Picture
Figure 7. Neisseria meningitidis Infections Drug Sales Market Share by Application in 2018
Figure 8. Hospital Picture
Figure 9. Clinic Picture
Figure 10. Others Picture
Figure 11. Global Neisseria meningitidis Infections Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Neisseria meningitidis Infections Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Neisseria meningitidis Infections Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Neisseria meningitidis Infections Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Neisseria meningitidis Infections Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Neisseria meningitidis Infections Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Neisseria meningitidis Infections Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Neisseria meningitidis Infections Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Neisseria meningitidis Infections Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Neisseria meningitidis Infections Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Neisseria meningitidis Infections Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Neisseria meningitidis Infections Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Neisseria meningitidis Infections Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Neisseria meningitidis Infections Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Neisseria meningitidis Infections Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Neisseria meningitidis Infections Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Neisseria meningitidis Infections Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Neisseria meningitidis Infections Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Neisseria meningitidis Infections Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Neisseria meningitidis Infections Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Neisseria meningitidis Infections Drug Sales Market Share by Manufacturer in 2019
Figure 32. Global Neisseria meningitidis Infections Drug Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Neisseria meningitidis Infections Drug Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Neisseria meningitidis Infections Drug Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Neisseria meningitidis Infections Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 37. Global Neisseria meningitidis Infections Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Neisseria meningitidis Infections Drug Revenue Market Share by Regions (2015-2020)
Figure 39. Global Neisseria meningitidis Infections Drug Revenue Market Share by Regions in 2018
Figure 40. North America Neisseria meningitidis Infections Drug Sales and Growth Rate (2015-2020)
Figure 41. Europe Neisseria meningitidis Infections Drug Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Neisseria meningitidis Infections Drug Sales and Growth Rate (2015-2020)
Figure 43. South America Neisseria meningitidis Infections Drug Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Neisseria meningitidis Infections Drug Sales and Growth Rate (2015-2020)
Figure 45. North America Neisseria meningitidis Infections Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Neisseria meningitidis Infections Drug Sales Market Share by Countries (2015-2020)
Figure 47. North America Neisseria meningitidis Infections Drug Sales Market Share by Countries in 2018
Figure 48. North America Neisseria meningitidis Infections Drug Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Neisseria meningitidis Infections Drug Revenue Market Share by Countries in 2018
Figure 50. United States Neisseria meningitidis Infections Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 51. Canada Neisseria meningitidis Infections Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 52. Mexico Neisseria meningitidis Infections Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 53. Europe Neisseria meningitidis Infections Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Neisseria meningitidis Infections Drug Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Neisseria meningitidis Infections Drug Revenue Market Share by Countries in 2019
Figure 56. Germany Neisseria meningitidis Infections Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 57. UK Neisseria meningitidis Infections Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 58. France Neisseria meningitidis Infections Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 59. Russia Neisseria meningitidis Infections Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. Italy Neisseria meningitidis Infections Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. Asia-Pacific Neisseria meningitidis Infections Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Neisseria meningitidis Infections Drug Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Neisseria meningitidis Infections Drug Revenue Market Share by Regions 2019
Figure 64. China Neisseria meningitidis Infections Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan Neisseria meningitidis Infections Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 66. Korea Neisseria meningitidis Infections Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 67. India Neisseria meningitidis Infections Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. Southeast Asia Neisseria meningitidis Infections Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. South America Neisseria meningitidis Infections Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Neisseria meningitidis Infections Drug Sales Market Share by Countries in 2019
Figure 71. South America Neisseria meningitidis Infections Drug Revenue Market Share by Countries in 2019
Figure 72. Brazil Neisseria meningitidis Infections Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 73. Argentina Neisseria meningitidis Infections Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 74. Middle East and Africa Neisseria meningitidis Infections Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Neisseria meningitidis Infections Drug Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Neisseria meningitidis Infections Drug Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Neisseria meningitidis Infections Drug Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Neisseria meningitidis Infections Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 79. Egypt Neisseria meningitidis Infections Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 80. Turkey Neisseria meningitidis Infections Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 81. South Africa Neisseria meningitidis Infections Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. Global Neisseria meningitidis Infections Drug Sales and Growth Rate (2021-2025) (K Pcs)
Figure 83. Global Neisseria meningitidis Infections Drug Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Neisseria meningitidis Infections Drug Market Forecast (2021-2025) (K Pcs)
Figure 85. Europe Sales Neisseria meningitidis Infections Drug Market Forecast (2021-2025) (K Pcs)
Figure 86. Asia-Pacific Sales Neisseria meningitidis Infections Drug Market Forecast (2021-2025) (K Pcs)
Figure 87. South America Sales Neisseria meningitidis Infections Drug Market Forecast (2021-2025) (K Pcs)
Figure 88. Middle East & Africa Sales Neisseria meningitidis Infections Drug Market Forecast (2021-2025) (K Pcs)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
ナイセリア淋病感染症治療の世界市場 2020年 Market Overview The global Neisseria Gonorrhoeae Infections Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Ne…- 類鼻疽菌感染症治療薬の世界市場 2020年 Market Overview The global Burkholderia Pseudomallei Infections Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Bur…
- ライノウイルス感染症治療薬の世界市場 2020年 Market Overview The global Rhinovirus Infections Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Rhinovirus Infecti…
- ロタウイルス感染症治療薬の世界市場 2020年 Market Overview The global Rotavirus Infections Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Rotavirus Infection…
- インフルエンザAウイルス・H3N2サブタイプ感染症治療薬の世界市場 2020年 Market Overview The global Influenza A Virus, H3N2 Subtype Infections Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. T…